Related Experiment Video

Updated: Nov 25, 2025

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

471

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?

Atul Batra1, Akash Kumar1

  • 1Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.

Breast (Edinburgh, Scotland)
|December 17, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Breast cancerHER2Prognosis

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.2K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.9K

Related Experiment Videos

Last Updated: Nov 25, 2025

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

471
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.2K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.9K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K

Articles linked to this work by shared authors, journal, and citation graph.

Decoding the Hydrogen-Transfer Synergy in Camellia oleifera Shell Hydrochar/HDPE Co-Pyrolysis: A Kinetic and Thermodynamic Perspective.

Polymers·2026

Re-Thinking Electronic Circuit Design Through Emerging Reconfigurable Field Effect Transistors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Mismatch Repair Pathway, MLH1, MSH2 and Mutations in Prostate Cancer.

International journal of surgical pathology·2026

Correlating the C-5 Induction Effect on Uracil-Based Nucleoside Lipid Nanoparticles for Enhanced Redox-Mediated Therapeutic Efficacy in Hepatocellular Carcinoma.

ACS applied bio materials·2026

Cost-Effectiveness of Early Empirical Antibiotic Cessation in Pediatric High-Risk Febrile Neutropenia.

Pediatric blood & cancer·2026

Anticipated Resection Ratio (ARR) Based Flap Selection for Volume-Replacement Oncoplastic Breast-Conserving Surgery: 130 Breast Cancer Patients Cohort From a South Asian Tertiary Cancer Center.

World journal of surgery·2026

8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines).

Breast (Edinburgh, Scotland)·2026

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort.

Breast (Edinburgh, Scotland)·2026

Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database.

Breast (Edinburgh, Scotland)·2026

Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence.

Breast (Edinburgh, Scotland)·2026

Prospective assessment of incomplete ovarian suppression in breast cancer using LC-MS/MS and immunoassays for estradiol.

Breast (Edinburgh, Scotland)·2026

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.

Breast (Edinburgh, Scotland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us